Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Water Environ Res ; 96(8): e11094, 2024 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-39114927

RESUMO

This study aims to conduct a comprehensive analysis of switching disinfectants from sodium hypochlorite bleach to chlorine dioxide (ClO2) in the water distribution system of Geyikbayiri, Antalya. For this purpose, bulk decay rates of ClO2 at various water temperatures were determined in laboratory studies. The study revealed ClO2 bulk decay rates of 0.12639 day-1, 0.17848 day-1, and 0.19621 day-1 at temperatures 15°C, 20°C, and 30°C, respectively. The EPANET, a widely employed computer program for simulating the extended-period behavior of hydraulic and water quality in pressurized pipes, was utilized for the analysis of the fate and transport of ClO2. A hydraulic model was first developed, calibrated, and verified using distinct data sets. The Hazen-Williams friction coefficient of the PSA was determined to be 120 by the trial-and-error method with a mean absolute error (MAE) of 0.408 m. A ClO2 model was then integrated with the calibrated and verified hydraulic model, revealing a wall decay rate of 0.01 m/day and an average MAE of 0.034 mg/l. After calibration and verification of the ClO2 model, several management scenarios were developed, and ClO2 dosing rates were determined. The study showed that ClO2 dosing rates of 0.40 mg/l and 0.45 mg/l should be applied to keep ClO2 concentrations within certain limits. PRACTITIONER POINTS: Disinfectants must maintain a sufficient residual in water distribution systems. Chlorine dioxide requires less contact time and is not affected by pH fluctuations. Modeling serves as a decision-making tool for the management of disinfectants. Bulk and wall decay rates of chlorine dioxide are crucial for management strategies. Chlorine dioxide is a good alternative as a disinfectant in such systems.


Assuntos
Compostos Clorados , Óxidos , Compostos Clorados/química , Óxidos/química , Modelos Teóricos , Desinfetantes/química , Abastecimento de Água , Poluentes Químicos da Água/química
2.
Basic Clin Pharmacol Toxicol ; 119(4): 367-75, 2016 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-27061450

RESUMO

The activation of Nod-like receptor protein 3 (NLRP3) has lately been implicated in stress and depression as an initiator mechanism required for the production of interleukin (IL)-1ß and IL-18. Agmatine, an endogenous polyamine widely distributed in mammalian brain, is a novel neurotransmitter/neuromodulator, with antistress, anxiolytic and antidepressant-like effects. In this study, we examined the effect of exogenously administered agmatine on NLRP3 inflammasome pathway/cytokine responses in rats exposed to restraint stress for 7 days. The rats were divided into three groups: stress, stress+agmatine (40 mg/kg; i.p.) and control groups. Agmatine significantly down-regulated the gene expressions of all stress-induced NLRP3 inflammasome components (NLRP3, NF-κB, PYCARD, caspase-1, IL-1ß and IL-18) in the hippocampus and prefrontal cortex (PFC) and reduced pro-inflammatory cytokine levels not only in both brain regions, but also in serum. Stress-reduced levels of IL-4 and IL-10, two major anti-inflammatory cytokines, were restored back to normal by agmatine treatment in the PFC. The findings of the present study suggest that stress-activated NLRP3 inflammasome and cytokine responses are reversed by an acute administration of agmatine. Whether antidepressant-like effect of agmatine can somehow, at least partially, be mediated by the inhibition of NLRP3 inflammasome cascade and relevant inflammatory responses requires further studies in animal models of depression.


Assuntos
Agmatina/uso terapêutico , Ansiolíticos/uso terapêutico , Antidepressivos/uso terapêutico , Proteína 3 que Contém Domínio de Pirina da Família NLR/antagonistas & inibidores , Neurônios/efeitos dos fármacos , Estresse Fisiológico/efeitos dos fármacos , Estresse Psicológico/tratamento farmacológico , Animais , Proteínas Reguladoras de Apoptose/antagonistas & inibidores , Proteínas Reguladoras de Apoptose/genética , Proteínas Reguladoras de Apoptose/metabolismo , Proteínas Adaptadoras de Sinalização CARD , Caspase 1/química , Caspase 1/genética , Caspase 1/metabolismo , Citocinas/antagonistas & inibidores , Citocinas/sangue , Citocinas/genética , Citocinas/metabolismo , Regulação da Expressão Gênica/efeitos dos fármacos , Hipocampo/efeitos dos fármacos , Hipocampo/imunologia , Hipocampo/metabolismo , Inflamassomos/agonistas , Inflamassomos/metabolismo , Masculino , NF-kappa B/antagonistas & inibidores , NF-kappa B/genética , NF-kappa B/metabolismo , Proteína 3 que Contém Domínio de Pirina da Família NLR/genética , Proteína 3 que Contém Domínio de Pirina da Família NLR/metabolismo , Proteínas do Tecido Nervoso/antagonistas & inibidores , Proteínas do Tecido Nervoso/genética , Proteínas do Tecido Nervoso/metabolismo , Neurônios/imunologia , Neurônios/metabolismo , Córtex Pré-Frontal/efeitos dos fármacos , Córtex Pré-Frontal/imunologia , Córtex Pré-Frontal/metabolismo , Ratos Sprague-Dawley , Restrição Física/efeitos adversos , Restrição Física/psicologia , Estresse Psicológico/imunologia , Estresse Psicológico/metabolismo , Estresse Psicológico/psicologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA